An exploratory 12-week pilot study of gut microbiota and body-weight patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in Wistar rats.
9 affiliations
- 1Department of Nutrition and Dietetics, Faculty of Health Sciences, Siirt University, Siirt, Türkiye. [email protected].
- 2Department of Nutrition and Dietetics, Faculty of Health Sciences, Ankara University, Ankara, Türkiye.
- 3Department of Nutrition and Dietetics, Faculty of Health Sciences, Atilim University, Ankara, Türkiye.
- 4Department of Biotechnology, Institute of Nanotechnology and Biotechnology, Istanbul University-Cerrahpaşa, Istanbul, Türkiye.
- 5Health Biotechnology Joint Research and Applications Center of Excellence, Istanbul, Türkiye.
- 6Vocational School of Health Services, Atilim University, Ankara, Türkiye.
- 7Centre for Laboratory Animal Breeding and Experimental Research (ATÜDEM), Atilim University, Ankara, Türkiye.
- 8Home Care Services, Medicana International Ankara Hospital, Ankara, Türkiye.
- 9Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istanbul Atlas University, Istanbul, Türkiye.
Abstract
Background
Sodium nitrite (E250) is a widely used additive in processed meat products and has been reported to disrupt the gut microbiota and exert carcinogenic effects via N-nitroso compounds. This exploratory pilot study examined body-weight and longitudinal gut-microbiota patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in adolescent Wistar rats.Methods
Sixty-four adolescent Wistar rats were allocated to Control, sodium nitrite (SN), Lactobacillus plantarum 299v (LP), or combined SN + LP groups for 12 weeks. Body weight was assessed in the full cohort. The exploratory microbiota component comprised 48 serial fecal samples from eight selected rats, with one male and one female from each treatment group. V3-V4 16S rRNA amplicons were sequenced on an Illumina iSeq 100 using a 2 × 150-bp paired-end configuration. Read 1 (R1) sequences were processed using the single-end DADA2 workflow, and microbiota profiles were analyzed descriptively.Results
Body-weight trajectories varied across groups and sexes in the full cohort. The descriptive relative-abundance profiles varied across sampling times. The sodium nitrite profile showed higher relative Proteobacteria abundance at several post-baseline time points, while longitudinal ordination trajectories overlapped substantially.Conclusions
The exploratory findings describe patterns across sampling times but do not establish group-level treatment effects or probiotic attenuation of nitrite-associated changes. Confirmation in adequately powered studies with independent cage-level replication is required.Clinical trial number
Not applicable.
Related
- Chickpea flour (Cicer arietinum L) improves viability of potentially probiotics Lactobacillus plantarum S180.7 and Lactobacillus plantarum SBR64.7 in milk-based formulations
- Enteric ChAT-Expressing Neurons Mediate the Protective Effect of Lactobacillus plantarum in Inflammatory Bowel Disease.
- Anti-inflammatory effects of vitamin K2 and Lactobacillus plantarum in a mouse model of colorectal cancer
- An Exploratory Randomized Clinical Trial to Assess the Effects of Vitamin D and Leucine-Enriched Whey Protein Supplementation on Inflammaging and Gut Eubacterial Biomass in Cardiac Rehabilitation Patients
- Postoperative inulin supplementation is associated with microbiota remodeling and improved colonic anastomotic healing in LPS-primed mice
BibTeX
@article{duman2026exploratory,
title = {{An exploratory 12-week pilot study of gut microbiota and body-weight patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in Wistar rats.}},
author = {Emre Duman and Alev Keser and Tuğçe Nur Balcı and Özlem Çetiner and Murat Kavruk and Ali Doğan Dursun and Veli Cengiz Özalp},
journal = {BMC microbiology},
year = {2026},
month = oct,
doi = {10.1186/s12866-026-05814-x},
url = {https://europepmc.org/article/MED/42919129},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - An exploratory 12-week pilot study of gut microbiota and body-weight patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in Wistar rats.
AU - Emre Duman
AU - Alev Keser
AU - Tuğçe Nur Balcı
AU - Özlem Çetiner
AU - Murat Kavruk
AU - Ali Doğan Dursun
AU - Veli Cengiz Özalp
PY - 2026
DA - 2026/10/19
JO - BMC microbiology
DO - 10.1186/s12866-026-05814-x
UR - https://europepmc.org/article/MED/42919129
AB - Background Sodium nitrite (E250) is a widely used additive in processed meat products and has been reported to disrupt the gut microbiota and exert carcinogenic effects via N-nitroso compounds. This exploratory pilot study examined body-weight and longitudinal gut-microbiota patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in adolescent Wistar rats.Methods Sixty-four adolescent Wistar rats were allocated to Control, sodium nitrite (SN), Lactobacillus plantarum 299v (LP), or combined SN + LP groups for 12 weeks. Body weight was assessed in the full cohort. The exploratory microbiota component comprised 48 serial fecal samples from eight selected rats, with one male and one female from each treatment group. V3-V4 16S rRNA amplicons were sequenced on an Illumina iSeq 100 using a 2 × 150-bp paired-end configuration. Read 1 (R1) sequences were processed using the single-end DADA2 workflow, and microbiota profiles were analyzed descriptively.Results Body-weight trajectories varied across groups and sexes in the full cohort. The descriptive relative-abundance profiles varied across sampling times. The sodium nitrite profile showed higher relative Proteobacteria abundance at several post-baseline time points, while longitudinal ordination trajectories overlapped substantially.Conclusions The exploratory findings describe patterns across sampling times but do not establish group-level treatment effects or probiotic attenuation of nitrite-associated changes. Confirmation in adequately powered studies with independent cage-level replication is required.Clinical trial number Not applicable.
SN - 1471-2180
ER -